Literature DB >> 11734760

Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes.

S C Buckingham1, J A McCullers, J Luján-Zilbermann, K M Knapp, K L Orman, B K English.   

Abstract

BACKGROUND: The relationship of antibiotic susceptibility to clinical outcome in children with pneumococcal meningitis is uncertain. Previous studies have been limited by inclusion of relatively few patients infected with nonsusceptible pneumococci and inconsistent use of empiric vancomycin.
METHODS: Medical records of 86 children with culture-confirmed pneumococcal meningitis at a single institution from October, 1991, to October, 1999, were retrospectively reviewed, and differences in presentation and outcome based on antibiotic susceptibility of pneumococcal isolates were assessed.
RESULTS: Of 86 isolates 34 were nonsusceptible to penicillin (12 resistant). Of 60 isolates for which cefotaxime susceptibility data were available, 17 were nonsusceptible (12 resistant). Antibiotic susceptibility was not significantly associated with death, intensive care unit admission, mechanical ventilation, focal neurologic deficits, seizures, secondary fever, abnormal neuroimaging studies or hospital days. Children with penicillin-resistant isolates had significantly higher median blood leukocyte counts (24,100/microliter vs. 15,700/microliter, P = 0.03) and lower median CSF protein concentrations (85 mg/dl vs. 219 mg/dl, P = 0.04), were more likely to have a CSF glucose concentration of > or = 50 mg/dl (7 of 11 vs. 15 of 68, P = 0.009) and had lower rates of sensorineural hearing loss (1 of 8 vs. 25 of 40, P = 0.02) than children with isolates that were not resistant to penicillin. Children with cefotaxime-nonsusceptible isolates had an increased median duration of primary fever compared with those with nonsusceptible strains (6 days vs. 3.5 days, P = 0.02).
CONCLUSIONS: In children with pneumococcal meningitis, penicillin resistance was associated with a reduced risk of hearing loss, while cefotaxime resistance was associated with a longer duration of fever. Other outcome measures were not significantly influenced by the antibiotic susceptibility of pneumococcal isolates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734760     DOI: 10.1097/00006454-200109000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Clinical implication of extended-spectrum cephalosporin nonsusceptibility in Streptococcus pneumoniae meningitis.

Authors:  S-H Choi; J-W Chung; B-N Kim; Y G Kwak; T H Kim; E J Lee; E J Choo; M-H Jeon; M S Lee; I-G Bae; S-R Lee; E H Song; J-B Jun; M-N Kim; S-H Kim; S-O Lee; Y S Kim; J H Woo; S-H Choi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-02       Impact factor: 3.267

2.  Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.

Authors:  Denis Grandgirard; Melchior Burri; Philipp Agyeman; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

3.  A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis.

Authors:  P B McIntyre; C R Macintyre; R Gilmour; H Wang
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

4.  The effect of vaccination on Streptococcus pneumoniae resistance.

Authors:  Eugene Leibovitz
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

5.  Clinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: an observational study.

Authors:  Edilane L Gouveia; Joice N Reis; Brendan Flannery; Soraia M Cordeiro; Josilene B T Lima; Ricardo M Pinheiro; Kátia Salgado; Ana Veronica Mascarenhas; M Gloria Carvalho; Bernard W Beall; Mitermayer G Reis; Albert I Ko
Journal:  BMC Infect Dis       Date:  2011-11-21       Impact factor: 3.090

6.  Reference group choice and antibiotic resistance outcomes.

Authors:  Keith S Kaye; John J Engemann; Essy Mozaffari; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.